Impact of primary care-based disease management on the health-related quality of life in patients with type 2 diabetes and comorbidity

Diabetes Care

Volumn 32, Issue 9, 2009, Pages 1594-1596

  Ose, Dominik ^a   Wensing, Michel ^a,b   Szecsenyi, Joachim ^a   Joos, Stefanie ^a   Hermann, Katja ^a   Miksch, Antje ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; GERMANY; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIMARY MEDICAL CARE; QUALITY OF LIFE; QUESTIONNAIRE;

AGED; COMORBIDITY; DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; FEMALE; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 69549128048     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-2223     Document Type: Article

References (15)

1. Wexler DJ, Grant RW, Wittenberg E, Bosch JL, Cagliero E, Delahanty L, Blais MA, Meigs JB. Correlates of health-related quality of life in type 2 diabetes. Diabetologia 2006;49:1489-1497 (Pubitemid 43848084)
2. U.K. Prospective Diabetes Study Group. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care 1999;22:1125-1136
3. Miksch A, Hermann K, Rölz A, Joos S, Szecsenyi J, Ose D, Rosemann T. Additional impact of concomitant hypertension and osteoarthritis on quality of life among patients with type 2 diabetes in primary care in Germany: a cross-sectional survey. Health Qual Life Outcomes 2009;7:19
4. Busse R. Disease management programs in Germany's statutory health insurance system. Health Aff (Millwood) 2004;23: 56-67
5. Szecsenyi J, Rosemann T, Joos S, Peters-Klimm F, Miksch A. German diabetes disease management programs are appropriate for restructuring care according to the chronic care model: an evaluation with the Patient Assessment of Chronic Illness Care instrument. Diabetes Care 2008;31:1150-1154
6. Joos S, Rosemann T, Heiderhoff M, Wensing M, Ludt S, Gensichen J, Kaufmann-Kolle P, Szecsenyi J. ELSID-Diabetes study-evaluation of a large scale implementation of disease management programmes for patients with type 2 diabetes: rationale, design and conduct: a study protocol [ISRCTN08471887]. BMC Public Health 2005;5:99 (Pubitemid 41518808)
7. EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy 1990;16: 199-208
8. Greiner W, Weijnen T, Nieuwenhuizen M, Oppe S, Badia X, Busschbach J, Buxton M, Dolan P, Kind P, Krabbe P, Ohinmaa A, Parkin D, Roset M, Sintonen H, Tsuchiya A, de Charro F. A single European currency for EQ-5D health states: results from a six-country study. Eur J Health Econ 2003;4:222-231 (Pubitemid 37247975)
9. Barton G, Sach T, Doherty M, Avery A, Jenkinson C, Muir K. An assessment of the discriminative ability of the EQ-5D index, SF-6D, and EQ VAS, using sociodemographic factors and clinical conditions. Eur J Health Econ 2008;9:237-249 (Pubitemid 351962397)
10. Grandy S, Fox KM. EQ-5D visual analog scale and utility index values in individuals with diabetes and at risk for diabetes: findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD). Health Qual Life Outcomes 2008;6:18-25
11. Dolan P. Modeling valuations for Euro-Qol health states. Med Care 1997;35: 1095-1108 (Pubitemid 127453463)
12. Rothe U, Müller G, Schwarz PEH, Seifert M, Kunath H, Koch R, Bergmann S, Julius U, Bornstein SR, Hanefeld M, Schulze J. Evaluation of a diabetes management system based on practice guidelines, integrated care, and continuous quality management in a federal state of Germany: a population-based approach to health care research. Diabetes Care 2008; 31:863-868
13. Smolders M, Laurant M, Van Rijswijk E, Mulder J, Braspenning J, Verhaak P, Wensing M, Grol R. Depressed and a comorbid condition: more psychotropics prescribed. Eur J Gen Pract 2008;14: 10-18 (Pubitemid 351973707)
14. Smolders M, Laurant M, Rijswijk E, Mulder J, Braspenning J, Verhaak P, Wensing M, Grol R. The impact of co-morbidity on GPs' pharmacological treatment decisions for patients with an anxiety disorder. Fam Pract 2007;25:538-546
15. Starfield B. Is primary care essential? Lancet 1994;344:1129-1133